#AI #Health
#Stock News: GBT (OTCPINK: $GTCH) is Working on its #qTerm
Device Improvements as a Preparation for its #FDA Certification Process
San Diego, CA, January 26, 2021 – (Investorideas.com Newswire) - GBT Technologies Inc. (OTCPINK: GTCH) ("GBT”, or the “Company”) via GBT Tokenize Corp (“GBT/Tokenize”) , has started a series of improvements for its qTerm device as preparations for FDA certification process. The series of improvements are targeting higher measurements accuracy, reliability and compatibility with a broad spectrum of user’s usage behavior. qTerm is aimed to measure human vitals with a touch of a finger. Based on prototype testing, debugging and study, conclusions were made in order to increase the device’s accuracy and stability as expected pre-requisites towards the company’s intentions to file for FDA certification. There is no guarantee that the company or GBT/Tokenize will receive FDA certification for the qTerm.
Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/01261qTerm-Preparation-FDA.asp
qTerm first release will
include body temperature, blood oxygen and heart rate vitals. The next release is
planned to include blood pressure measurement. In order to increase consistency
with user’s measurement habits, the device’s sensors will be re-located to more
efficient positions to enable best and consistent results. For example,
different users may press their finger using different pressure, and position.
The body heat sensor’s accuracy is highly dependent on its distance from the
finger’s skin. A new location of the IR (Infra-Red) sensor will be defined to
enable an optimum distance to accommodate different user’s pressing pressure
and position. The heart rate and SPO2 (Blood Oxygen) sensor needs a direct skin
contact again with proper adjustments to different user’s finger’s pressure,
position and stability. An additional microchip will be installed to provide an
expert algorithm to support broad user’s measuring habits, compensating for
different inputs, and providing a consistent results for heart rate and blood
oxygen data. The device will be accompanied by a smartphone app and synchronized
web application to keep a history and provide analytics for user's records. It
is the goal for the web application to provide a geographical location and proximity
alert to assist with potential health risks. The series of modifications are
done as preparations for an FDA certification to classify qTerm as a medical
device to be marketed and sold in the US. The certification process is also aimed
to define the device for telemedicine purposes enabling remote vitals results
to be sent to clinics and hospitals for physicians review in real time.
"We believe these
changes will significantly increase the device’s performance, accuracy, and
consistency we are required to meet during the FDA certification. We believe
these changes will ensure the product's safety, accuracy, and reliability along
with high quality and efficiency. This technology, assuming we receive FDA
certification of which there is no guarantee, is planned to be marketed and
sold for personal and clinics usage also targeting it for the telemedicine
arena. Another aspect is the device’s planned Artificial Intelligence
technology that will be offering advanced features like real-time health
statistics, analytics, monitoring and real time, geographically proximity alert
to assist with avoiding health risks. The modifications also are focus on human
engineering aspect in order to ensure easier usability for the vitals measurements
like finger’s position pointers and physical finger’s location structural
design. We put extra emphasis on making the device easy for use, mainly
intuitive. Vitals results can be crucial indicators to assist with early
detection of illness and we are working to improve the device’s performance and
capabilities as preparations efforts for FDA clearance. It is in our R&D
culture to constantly improve our technology in efforts to bring it to the
highest standards and regulations, particularly in the medicine domain when it
can save lives." Said Danny Rittman GBT/Tokenize and the Company’s CTO.
About Us
GBT Technologies, Inc.
(OTC PINK: GTCH) (“GBT”) (http://gbtti.com)
is a development stage company which considers itself a native of Internet of
Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology
Platforms used to increase IC performance. GBT has assembled a team with
extensive technology expertise and is building an intellectual property
portfolio consisting of many patents. GBT’s mission, to license the technology
and IP to synergetic partners in the areas of hardware and software. Once
commercialized, it is GBT’s goal to have a suite of products including smart
microchips, AI, encryption, Blockchain, IC design, mobile security
applications, database management protocols, with tracking and supporting cloud
software (without the need for GPS). GBT envisions this system as a creation of
a global mesh network using advanced nodes and super performing new generation
IC technology. The core of the system will be its advanced microchip technology;
technology that can be installed in any mobile or fixed device worldwide. GBT’s
vision is to produce this system as a low cost, secure, private-mesh-network
between any and all enabled devices. Thus, providing shared processing,
advanced mobile database management and sharing while using these enhanced
mobile features as an alternative to traditional carrier services.
Forward-Looking
Statements
Certain statements contained in this press
release may constitute "forward-looking statements". Forward-looking
statements provide current expectations of future events based on certain
assumptions and include any statement that does not directly relate to any historical
or current fact. Actual results may differ materially from those indicated by
such forward-looking statements as a result of various important factors as
disclosed in our filings with the Securities and Exchange Commission located at
their website (http://www.sec.gov).
In addition to these factors, actual future performance, outcomes, and results
may differ materially because of more general factors including (without limitation)
general industry and market conditions and growth rates, economic conditions,
governmental and public policy changes, the Company’s ability to raise capital
on acceptable terms, if at all, the Company’s successful development of its
products and the integration into its existing products and the commercial acceptance
of the Company’s products. The forward-looking statements included in
this press release represent the Company's views as of the date of this press
release and these views could change. However, while the Company may
elect to update these forward-looking statements at some point in the future,
the Company specifically disclaims any obligation to do so. These
forward-looking statements should not be relied upon as representing the
Company's views as of any date subsequent to the date of the press release.
Contact:
Dr. Danny Rittman, CTO
press@gopherprotocol.com
GBT Technologies
Inc. (OTCQB:GTCH) is a featured tech stock on
More info on GTCH at
Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/
Get
News Alerts on GBT Technologies Inc GTCH
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Disclosure: GTCH is a PR, social media and publishing client and
compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp
Contact management and IR of each company directly
regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Get more tech stocks investor ideas- news, articles, podcasts and stock directories
|
